Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
09/2008
09/10/2008EP1966181A2 Anthranilic acid derivatives useful in treating infection with hepatitis c virus
09/10/2008EP1965832A1 Gastrointestinal function promoter
09/10/2008CN101263107A Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
09/09/2008US7423181 Aminoalkoxy-functional chalcones
09/09/2008US7423161 Dithiocarboxylates, dithiocarbonates and trithiocarbonates in which the ester group is 1-substituted with a hydroxy, ether, amine or halo group, e.g., 1-(N-acetylamino)-2,2,2-trifluoroethyl]-O-ethyl dithiocarbonate and 1-ethoxythiocarbonylsulphanyl-2,2,2-trifluoro-ethyl ester of benzoic acid
09/09/2008US7423154 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates
09/09/2008US7423030 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
09/09/2008CA2419696C Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes
09/09/2008CA2211646C Substituted phenyl compounds as endothelin antagonists
09/04/2008US20080214661 Process To Obtain Dibenzylbutyrolactonic, Tetrahydrofuranic Lignans And Their Synthetic And Semi-Synthetic Derivatives, Their Analgesic And Anti-Inflammatory Activities, Topical And/Or Systemic Formulations Containing Said Lignans And Their Respective Therapeutic Method
09/03/2008EP1963301A1 Process for preparing glyceryl carbonate
09/03/2008EP1963260A1 Process for the production of ezetimibe and intermediates used in this proces
09/03/2008EP1963256A1 Higher fatty acid triester and amide derivative having diethylenetriamine-type metal chelate structure
09/03/2008CN101258119A Process for preparing 3,4-dioxo-substituted aromatic aldehydes
09/03/2008CN101257900A Gsk-3 inhibitors
09/03/2008CN100415734C 1-acetoxy-3-(substituted phenyl) propen compounds useful as an intermediate material
09/03/2008CN100415733C Process for the preparation of propylene carbonate
09/03/2008CN100415705C Bicyclo[3.3.1]nonanes and bicyclo[3.3.1]nonenes and their use as flavour or fragrance ingredient
09/02/2008US7420089 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
09/02/2008US7420003 Compounds and a novel process for their preparation
09/02/2008US7419980 Treating conditions improved by monoamine reuptake; 1-[1-(2-naphthyl)-2-piperazin-1-ylethyl]cyclobutanol; sexual disorders, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders, hot flashes
09/02/2008CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors
08/2008
08/28/2008US20080207927 Process for the production of glycerol acetals
08/28/2008US20080207482 Perfumes; 3,5-dioxatricyclo(6.2.1.0(2,6))undecane
08/28/2008DE10333368B4 Oberflächenfunktionalisiertes Trägermaterial, Verfahren zu dessen Herstellung und dessen Verwendungen Surface-functionalised carrier material, process for its preparation and its uses
08/27/2008EP1959944A1 A pharmaceutical composition comprising an amide derivative
08/27/2008CN101250179A Chemosynthesis method of 4-bromomethyl-5-methyl-1,3-dioxy heterocyclic pentene-2-ketone
08/27/2008CN101250178A Chemosynthesis method of 4-chloromethyl-5-methyl-1,3-dioxy heterocyclic pentene-2-ketone
08/27/2008CN100413861C Compounds and methods for the treatment or prevention of flavivirus infections
08/26/2008US7417172 Perfluoroalkyl vinyl ether compound, process for preparing copolymer by using the compound, and optical plastic materials comprising copolymer prepared by the process
08/26/2008US7417153 cis hydroxylation of the double bond of 2-acetyl-2-azabicyclo[2.2.1]hept-5-en-3-one into a 2-acetyl-5,6-dihydroxy-2-azabicyclo[2.2.1]heptan-3-one, reacting intemediate with aldehyde or ketone or with 2,2-dimethoxypropane into a ketal or acetal, reductive ring opening, then alkaline hydrolysis
08/26/2008US7417145 Process for total synthesis of ecteinascidins and intermediates therefor
08/21/2008WO2008099882A1 2-methyl-3-(3,4-methylenedioxyphenyl)propanal, and method for production thereof
08/21/2008WO2008098375A1 Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
08/21/2008WO2007109365A3 Process for the synthesis of arylamines from the reaction of an aromatic compound with ammonia or a metal amide
08/21/2008US20080200697 Process for the preparation of 1-aryl-3,4-dihydro-1H-naphthalene-2-one
08/21/2008US20080200551 Flourene Derivative
08/20/2008EP1249233B1 Npyy5 antagonists
08/20/2008CN101248041A 鞘氨醇激酶抑制剂 Sphingosine kinase inhibitors
08/20/2008CN101245060A Method for producing N-alkyl-(3,4-methylenedioxy) aniline
08/20/2008CN101245059A Preparation for treating rheumatism, rheumatoid disease with caulis piperis futokadsurae amide as efficacy component
08/20/2008CN101245058A Inhibitors of aspartyl protease
08/20/2008CN100412072C Novel fluorine-containing dioxolane compound and novel fluorine-containing polymer
08/19/2008US7414157 Hydroxylation of β-dicarbonyls with zirconium catalysts
08/19/2008US7414147 transesterifying methyl methacrylate with glycerol carbonate in the presence of a stabilizer and zinc acetylacetonate as metal chelating catalyst, precipitating the catalyst with phosphoric acid, separating off the filtrate
08/14/2008WO2008098077A2 Substituted alkine derivatives as anti-cancer agents
08/14/2008WO2008095328A1 A kind of hydrochloric piperphentonamine freeze-dried powder injection, preparation methods and uses thereof
08/14/2008US20080194697 ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane, used for treating prostate cancer, prostatitis and benign prostatic hyperplasia
08/14/2008US20080194678 Process To Obtain Synthetic And Semi-Synthetic Lignan Derivatives, Their Antiparasitic Activities And Corresponding Pharmaceutical Formulations, Including The Therapeutic Method Using Said Lignan For The Treatment Of Parasitosis
08/14/2008US20080194650 Aryl fluoroethyl ureas acting as alpha 2 adrenergic agents
08/13/2008EP1955996A1 7, 9-Substituted tetracycline compounds
08/13/2008EP1954687A2 Adducts of levulinic derivatives with epoxidized fatty acid esters and uses thereof
08/13/2008EP1954678A1 Novel nk1 and nk2 antagonists
08/13/2008EP1954140A2 Glycerol levulinate ketals and their use
08/13/2008EP1368305B1 7, 9-substituted tetracycline compounds
08/13/2008EP1322309B1 High affinity small molecule c5a receptor modulators
08/13/2008CN101243030A Method for producing 4-halocatechol compound
08/13/2008CN101239965A Method for preparing cyclic carbonates from carrying hydroxyl ionic liquid
08/13/2008CN100410247C Method for synthesizing cyclic carbonate from carbon dioxide and epoxy compound through reaction of cycloaddition
08/13/2008CN100410236C Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps)
08/13/2008CN100409844C Noval compound, its synthetizing process and therapeutic use
08/12/2008US7411001 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
08/12/2008US7410969 Antitumoral analogs of ET-743
08/06/2008EP1311475B1 Aminocyclohexane derivatives
08/06/2008CN101238113A Process for the preparation of alkylene carbonates
08/06/2008CN101235027A Xanthiphenylketamine crystal and its preparation method and medical use
08/06/2008CN101235026A 4'-dialkoxymethyldicyclohexyl-4-methanol and preparation method thereof
08/05/2008US7407988 Active compounds with carbamic acid for diseases such as cancer, leukemia, atheriosclerosis, alzheimers disease or arthritis
08/05/2008CA2331593C Metabolites of ecteinascidin 743
07/2008
07/31/2008WO2008090731A1 Method for producing 2-nitroimidazole derivative
07/31/2008WO2008090046A1 Alternate process for preparing 3,5-di-omicron-acyl-2-fluoro-2-c-methyl-d-ribono-gamma-lactone
07/31/2008WO2008068423A3 P<0}{0pyrrol derivatives, preparation and use of the same in therapy<0}
07/31/2008US20080182968 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
07/30/2008EP1950201A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
07/29/2008US7405230 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs
07/29/2008CA2348742C Carbocyclic potassium channel inhibitors
07/29/2008CA2218096C New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds
07/29/2008CA2214323C Compounds and compositions for delivering active agents
07/24/2008US20080176852 Biguanide and dihydrotriazine derivatives
07/24/2008US20080176849 e.g. N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]-amino]methyl]phenyl]-2E-2-propenamide; histone deacetylase inhibitor; anticarcinogenic, antitumor, antiproliferative agents; improved stability
07/24/2008US20080176842 N1-[1-[N-(2-methylpropyl)-N-(phenylsulfonyl)amino]-2R-hydroxy-3S-(phenylmethyl)prop-3-yl]-3-(1-morpholinosulfonyl)-2R-methylpropionamide; viricide; human T-cell leukemia/limphoma virus
07/23/2008EP1946757A1 Atr inhibitor
07/23/2008EP1945689A1 Process for producing trioxane and at least one comonomer
07/23/2008EP1567514B1 Method for producing an aliphatic dialdehyde monoacetal
07/23/2008EP1071680B1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors
07/23/2008CN100404527C Chiral 4,4'-dimethoxy-5,6,5',6'-bis methylene dioxy -2,2'-phthalic acid derivatives and process for preparing same
07/23/2008CN100404493C Process for the preparation of propylene glycol
07/22/2008US7402709 Process for synthesizing heliotropine and its derivatives
07/22/2008US7402698 1-[2-(benzylamino)-1-(3,4-dichlorophenyl)ethyl]cyclobutanol hydrochloride; norepinephrine reuptake inhibitor; antidepressant, analgesic; vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, sleep disorder, hormone replacement syndrome
07/22/2008CA2313638C Cyclohexene carboxylates as neuraminidase inhibitors
07/17/2008WO2008051244A3 Anthranilic acid derivatives useful in treating infection with hepatitis c virus
07/17/2008US20080171767 N-substituted-2-alkylthio-2-(substituted aryloxy and heteroaryloxy)alkylamides and their sulphinyl and sulphonyl derivatives such as 2-(3,5-dichlorophenoxy)-2-methylthio-N-2-methylprop-2-yl acetamide; fungal infections of plants
07/16/2008CN101223130A Glutamate aggrecanase inhibitors
07/15/2008CA2279620C 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4)
07/10/2008US20080167378 For the 14273 peroxisome proliferator activated receptor; antidiabetic agents, hyperlipidemia, obesity or anorexia; receptor binding assay; drug screening kits
07/09/2008EP1940814A1 Piperazine derivatives as antimalarial agents
07/09/2008EP1940782A1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors
07/09/2008EP1673084B1 1-2' (1,4'-biperidin-1'-yl)-1-(phenyl)-ethylcyclohexanol derivatives as monoamine reuptake modulators for the treatment of vasomotor symptoms
07/09/2008EP1042841B1 Non-aqueous electrolyte for electrochemical systems and lithium secondary battery comprising the same
07/09/2008CN101218223A Benzodioxane and benzodioxolane derivatives and uses thereof
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 183